Synapse - Gynecologic Medicine Service

Results (2180)

Outcomes for patients (pts) with advanced endometrial cancer (aEC) who completed pembrolizumab (pembro) and continued lenvatinib (LEN) in the phase III Study 309/ KEYNOTE-775

Meeting Abstract

Colomba, E.; Lorusso, D.; Mackay, H.; Moore, R.; Yonemori, K.; Kim, Y. M.; Sanli, U. A.; Xie, R.; Barresi, G.; McKenzie, J.; more...
Annals of Oncology (2023)

Fulltext@MSK | Save

Ubamatamab (MUC16xCD3 bispecific antibody) with cemiplimab (anti-PD-1 antibody) in recurrent ovarian cancer: Phase I dose-escalation study

Meeting Abstract

O'Cearbhaill, R. E.; Moore, K. N.; Yeku, O.; Liu, J. F.; Bouberhan, S.; Hamilton, E. P.; Hou, J. Y.; Van Nieuwenhuysen, E.; Papadimitriou, K.; Yoo, S. Y.; more...
Annals of Oncology (2023)

Fulltext@MSK | Save

A phase I study of PRT3789, a potent and selective degrader of SMARCA2 in patients with advanced or metastatic solid tumors and a SMARCA4 mutation

Meeting Abstract

Dagogo-Jack, I.; Dowlati, A.; Guo, R.; Awad, M. M.; Swalduz, A.; Calvo, E.; Garcia, V. M.; Adjei, A. A.; Lorusso, P.; Punekar, S.; more...
Annals of Oncology (2023)

Fulltext@MSK | Save

Ifinatamab deruxtecan (I-DXd; DS-7300) in patients with advanced solid tumors: Updated clinical and biomarker results from a phase I/II study

Meeting Abstract

Patel, M. R.; Doi, T.; Koyama, T.; Falchook, G. S.; Friedman, C. F.; Piha-Paul, S. A.; Gutierrez, M.; Awad, M. M.; Mattour, A. H.; Satoh, T.; more...
Annals of Oncology (2023)

Fulltext@MSK | Save

DB-1305 (a Trop-2 targeted antibody-drug-conjugate [ADC]) in patients (pts) with advanced solid tumors: Preliminary clinical results from the phase (Ph) I/IIa study

Meeting Abstract

Marathe, O.; Cheng, Y.; Spira, A. I.; Hamilton, E. P.; Rubinstein, M. M.; Dong, X.; Li, L.; Lv, D.; Shi, J.; Gabrail, N.; more...
Annals of Oncology (2023)

Fulltext@MSK | Save

DESTINY-PanTumor02 study of trastuzumab deruxtecan (T-DXd) in patients (pts) with HER2-expressing solid tumors: Exploratory biomarker analyses of HER2 expression and gene amplification in tissue and plasma

Meeting Abstract

Makker, V.; Lee, J. Y.; Oh, D. Y.; Oaknin, A.; Puvvada, S. D.; Cecchi, F.; McEwen, R.; Michelini, F.; Meric-Bernstam, F.
Annals of Oncology (2023)

Fulltext@MSK | Save

HER2 genetic intratumor heterogeneity is associated with resistance to trastuzumab and trastuzumab emtansine therapy in recurrent high-grade endometrial cancer

Journal Article

Shen, S.; Ma, W.; Brown, D.; Da Cruz Paula, A.; Zhou, Q.; Iaosonos, A.; Tessier-Cloutier, B.; Ross, D. S.; Troso-Sandoval, T.; Reis-Filho, J. S.; more...
Modern Pathology (2023)

Fulltext@MSK | Save

Tisotumab vedotin in combination with carboplatin, pembrolizumab, or bevacizumab in recurrent or metastatic cervical cancer: Results from the innovaTV 205/GOG-3024/ENGOT-cx8 study

Journal Article

Vergote, I.; Van Nieuwenhuysen, E.; O'Cearbhaill, R. E.; Westermann, A.; Lorusso, D.; Ghamande, S.; Collins, D. C.; Banerjee, S.; Mathews, C. A.; Gennigens, C.; more...
Journal of Clinical Oncology (2023)

Fulltext@MSK | Save

Synoptic reporting for pretreatment CT examination in patients with advanced ovarian cancer: Impact on documentation of disease sites and physician satisfaction

Journal Article

Andrieu, P. C.; Nikolovski, I.; Juluru, K.; Sadowski, E.; Gangai, N.; Zheng, J.; Capanu, M.; Praiss, A. M.; Nougaret, S.; Shinagare, A. B.; more...
American Journal of Roentgenology (2023)

Fulltext@MSK | Save

Modern associations of uterine carcinomas with prior exposure to tamoxifen

Meeting Abstract

Rios-Doria, E.; Hodgson, A.; Aviki, E.; Zivanovic, O.; Friedman, C.; Aghajanian, C.; Makker, V.; Liu, Y.; Zamarin, D.; Leitao, M.; more...
Gynecologic Oncology (2023)

Fulltext@MSK | Save